We are live on ! Find out more
PALI icon

Palisade Bio

5 hedge funds and large institutions have $1.26M invested in Palisade Bio in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 55 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

35% less capital invested

Capital invested by funds: $1.94M → $1.26M (-$683K)

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$31K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$583K
ACM
2
Alethea Capital Management
Washington
$182K
William Blair & Company
3
William Blair & Company
Illinois
$97K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$92K
BlackRock
5
BlackRock
New York
$78K
LTFS
6
Ladenburg Thalmann Financial Services
Florida
$42K
PAM
7
Panagora Asset Management
Massachusetts
$35K
Northern Trust
8
Northern Trust
Illinois
$29K
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$23K
VF
10
Virtu Financial
New York
$23K
BRWA
11
B. Riley Wealth Advisors
Florida
$20K
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$13K
BF
13
BOK Financial
Oklahoma
$11K
Wells Fargo
14
Wells Fargo
California
$8K
UBS Group
15
UBS Group
Switzerland
$6K
CG
16
Cutler Group
California
$5K
CA
17
Centerpoint Advisors
Massachusetts
$3K
Group One Trading
18
Group One Trading
Illinois
$3K
Morgan Stanley
19
Morgan Stanley
New York
$3K
RCAG
20
Rehmann Capital Advisory Group
Michigan
$1.45K
Bank of America
21
Bank of America
North Carolina
$1K
MSA
22
Marino Stram & Associates
Massachusetts
$1K
RE
23
RBC Europe
United Kingdom
$18
Citadel Advisors
24
Citadel Advisors
Florida
-$31K

PALI Hedge Fund Activity: Q2 2018 in Review

5 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2018, worth a combined $1.26M — down 35% from $1.94M a quarter earlier.

Fund positioning in PALI was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Citadel Advisors, cutting an estimated $31K.

  • 5 institutional investors held Palisade Bio (PALI) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $1.26M of Palisade Bio stock for Q2 2018, down 35% quarter-over-quarter.
  • 0 funds opened new Palisade Bio positions in Q2 2018 and 0 closed out.
  • The largest Palisade Bio seller in Q2 2018 was Citadel Advisors, an estimated $31K sold.

Based on aggregated 13F filings for Q2 2018.